Dashboard
Manage Tickers

DRRX DURECT CORP

Nasdaq durect.com


$ 1.94 $ -0.02 (-1.04 %)    

Wednesday, 10-Sep-2025 17:31:26 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 618.13 $ 2.14 (0.35 %)
DIA $ 472.88 $ 3.02 (0.64 %)
SPY $ 678.13 $ 1.65 (0.24 %)
TLT $ 91.54 $ -0.02 (-0.02 %)
GLD $ 378.45 $ -0.06 (-0.02 %)
$ 1.91
$ 1.93
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 0.48 - $ 2.64
2,787,659
na
59.31M
$ 0.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 08-10-2023 06-30-2023 10-Q
9 05-09-2023 03-31-2023 10-Q
10 03-08-2023 12-31-2022 10-K
11 11-03-2022 09-30-2022 10-Q
12 08-05-2022 06-30-2022 10-Q
13 05-05-2022 03-31-2022 10-Q
14 03-08-2022 12-31-2021 10-K
15 11-03-2021 09-30-2021 10-Q
16 07-30-2021 06-30-2021 10-Q
17 05-05-2021 03-31-2021 10-Q
18 03-05-2021 12-31-2020 10-K
19 11-03-2020 09-30-2020 10-Q
20 08-04-2020 06-30-2020 10-Q
21 05-11-2020 03-31-2020 10-Q
22 03-05-2020 12-31-2019 10-K
23 11-05-2019 09-30-2019 10-Q
24 08-02-2019 06-30-2019 10-Q
25 05-07-2019 03-31-2019 10-Q
26 03-08-2019 12-31-2018 10-K
27 11-08-2018 09-30-2018 10-Q
28 08-02-2018 06-30-2018 10-Q
29 05-09-2018 03-31-2018 10-Q
30 03-08-2018 12-31-2017 10-K
31 11-02-2017 09-30-2017 10-Q
32 08-09-2017 06-30-2017 10-Q
33 05-10-2017 03-31-2017 10-Q
34 03-15-2017 12-31-2016 10-K
35 11-01-2016 09-30-2016 10-Q
36 08-02-2016 06-30-2016 10-Q
37 05-06-2016 03-31-2016 10-Q
38 03-01-2016 12-31-2015 10-K
39 11-03-2015 09-30-2015 10-Q
40 08-04-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Bausch Health To Acquire DURECT For $63M, ...
08/12/2025 20:51:09

Recent business highlights and updates:In July 2025, DURECT announced that it entered into an Agreement and Plan of Merger with...

durect-q2-eps-007-beats-011-estimate-sales-447000k-beat-310000k-estimate
Durect Q2 EPS $(0.07) Beats $(0.11) Estima...
08/12/2025 20:36:48

Durect (NASDAQ:DRRX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by 36....

bausch-health-adds-late-stage-ready-alcohol-liver-disease-drug-candidate-in-63-million-durect-buyout
Bausch Health Adds Late-Stage Ready Alcoho...
07/29/2025 18:21:25

Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via P...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 17:06:19

crude-oil-gains-over-1-unitedhealth-earnings-miss-views
Crude Oil Gains Over 1%; UnitedHealth Earn...
07/29/2025 16:53:28

us-stocks-mixed-procter--gamble-posts-upbeat-earnings
US Stocks Mixed; Procter & Gamble Posts Up...
07/29/2025 14:13:18

durect-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-3288
DURECT Shares Halted On Circuit Breaker To...
07/29/2025 14:03:30

durect-shares-resume-trade-following-circuit-breaker-halt
DURECT Shares Resume Trade Following Circu...
07/29/2025 13:58:39

Core News & Articles
Reported Earlier: Bausch Health To Acquire...
07/29/2025 13:56:06

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 12:07:53

trading-halt-halt-status-updated-at-72500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
07/29/2025 11:25:06

trading-halt-halted-at-65500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:55:00 a.m. ET - ...
07/29/2025 10:55:04

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
06/06/2025 12:07:07

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
05/16/2025 21:05:51

durect-q1-eps-013-misses-012-estimate-sales-32100k-beat-29167k-estimate
Durect Q1 EPS $(0.13) Misses $(0.12) Estim...
05/13/2025 20:23:53

Durect (NASDAQ:DRRX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.12) by 8...

hc-wainwright--co-reiterates-neutral-on-durectto-neutral
HC Wainwright & Co. Reiterates Neutral on ...
03/27/2025 17:26:50

HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) from Neutral to Neutral.

durect-q4-2024-gaap-eps-024-beats-002-estimate-sales-500000k-miss-6907m-estimate
Durect Q4 2024 GAAP EPS $0.24 Beats $(0.02...
03/26/2025 20:11:39

Durect (NASDAQ:DRRX) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.02) by 130...

earnings-scheduled-for-march-26-2025
Earnings Scheduled For March 26, 2025
03/26/2025 08:32:12

durect-sells-alzet-osmotic-pumps-for-175m-pays-off-loan-obligations
DURECT Sells ALZET Osmotic Pumps for $17.5...
11/25/2024 11:05:17

DURECT Corporation (NASDAQ:DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to ...

hc-wainwright--co-reiterates-neutral-on-durect
HC Wainwright & Co. Reiterates Neutral on ...
11/14/2024 11:20:39

HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) with a Neutral.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION